These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 3130680

  • 1. Platelets and the puzzles of pulmonary pyrrolizidine poisoning.
    Roth RA, Ganey PE.
    Toxicol Appl Pharmacol; 1988 May; 93(3):463-71. PubMed ID: 3130680
    [Abstract] [Full Text] [Related]

  • 2. 5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole.
    Ganey PE, Roth RA.
    Toxicol Appl Pharmacol; 1987 Apr; 88(2):157-64. PubMed ID: 3564035
    [Abstract] [Full Text] [Related]

  • 3. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite.
    Roth RA, Reindel JF.
    Adv Exp Med Biol; 1991 Apr; 283():477-87. PubMed ID: 1906225
    [Abstract] [Full Text] [Related]

  • 4. Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats.
    White SM, Wagner JG, Roth RA.
    Toxicol Appl Pharmacol; 1989 Jun 15; 99(2):302-13. PubMed ID: 2734793
    [Abstract] [Full Text] [Related]

  • 5. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
    Ganey PE, Sprugel KH, Hadley KB, Roth RA.
    J Pharmacol Exp Ther; 1986 Apr 15; 237(1):226-31. PubMed ID: 2937908
    [Abstract] [Full Text] [Related]

  • 6. Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia.
    Ganey PE, Sprugel KH, White SM, Wagner JG, Roth RA.
    Am J Physiol; 1988 Nov 15; 255(5 Pt 2):H1165-72. PubMed ID: 3189578
    [Abstract] [Full Text] [Related]

  • 7. Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity.
    Bruner LH, Carpenter LJ, Hamlow P, Roth RA.
    Toxicol Appl Pharmacol; 1986 Sep 30; 85(3):416-27. PubMed ID: 3094196
    [Abstract] [Full Text] [Related]

  • 8. Thromboxane does not mediate pulmonary vascular response to monocrotaline pyrrole.
    Ganey PE, Roth RA.
    Am J Physiol; 1987 Apr 30; 252(4 Pt 2):H743-8. PubMed ID: 2952022
    [Abstract] [Full Text] [Related]

  • 9. Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension.
    Hilliker KS, Bell TG, Lorimer D, Roth RA.
    Am J Physiol; 1984 Jun 30; 246(6 Pt 2):H747-53. PubMed ID: 6742140
    [Abstract] [Full Text] [Related]

  • 10. 6-Ketoprostaglandin F1 alpha and thromboxane B2 in isolated, blood-perfused lungs from monocrotaline pyrrole-treated rats.
    Ganey PE, Roth RA.
    J Toxicol Environ Health; 1988 Jun 30; 23(1):127-37. PubMed ID: 3336057
    [Abstract] [Full Text] [Related]

  • 11. Pulmonary platelet sequestration is increased following monocrotaline pyrrole treatment of rats.
    White SM, Roth RA.
    Toxicol Appl Pharmacol; 1988 Dec 30; 96(3):465-75. PubMed ID: 2974653
    [Abstract] [Full Text] [Related]

  • 12. Monocrotaline pyrrole-induced pulmonary hypertension in fawn-hooded rats with platelet storage pool deficiency: 5-hydroxytryptamine uptake by isolated, perfused lungs.
    Hilliker KS, Bell TG, Roth RA.
    Thromb Haemost; 1983 Dec 30; 50(4):844-7. PubMed ID: 6665765
    [Abstract] [Full Text] [Related]

  • 13. Arachidonic acid metabolites and the mechanisms of monocrotaline pneumotoxicity.
    Roth RA, Ganey PE.
    Am Rev Respir Dis; 1987 Sep 30; 136(3):762-5. PubMed ID: 2820283
    [Abstract] [Full Text] [Related]

  • 14. An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrrole.
    Schultze AE, Wagner JG, Roth RA.
    Toxicol Appl Pharmacol; 1991 Jul 30; 109(3):421-31. PubMed ID: 1830177
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of immunosuppressants and adoptive transfer in monocrotaline pyrrole pneumotoxicity.
    Bruner LH, Bull RW, Roth RA.
    Toxicol Appl Pharmacol; 1987 Oct 30; 91(1):1-12. PubMed ID: 3672514
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Early indications of monocrotaline pyrrole-induced lung injury in rats.
    Schultze AE, Wagner JG, White SM, Roth RA.
    Toxicol Appl Pharmacol; 1991 Jun 01; 109(1):41-50. PubMed ID: 2038748
    [Abstract] [Full Text] [Related]

  • 19. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
    Pan LC, Wilson DW, Lamé MW, Jones AD, Segall HJ.
    Toxicol Appl Pharmacol; 1993 Jan 01; 118(1):87-97. PubMed ID: 8430429
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.